QCG
Quadrant Capital Group Portfolio holdings
AUM
$2.78B
1-Year Return
19.13%
This Quarter Return
-3.74%
1 Year Return
+19.13%
3 Year Return
+73.37%
5 Year Return
+122.71%
10 Year Return
+247.64%
AUM
$826M
AUM Growth
-$12.2M
(-1.5%)
Cap. Flow
+$30.1M
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
31.84%
Holding
2,811
New
181
Increased
1,184
Reduced
709
Closed
182
Top Buys
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
$9.7M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$3.93M |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
$2.7M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$1.56M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$1.43M |
Top Sells
| 1 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
$7.89M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
$2.34M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
$1.68M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
$869K |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$781K |
Sector Composition
| 1 | Technology | 13.18% |
| 2 | Healthcare | 7.19% |
| 3 | Consumer Staples | 7.15% |
| 4 | Financials | 6.93% |
| 5 | Consumer Discretionary | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vertex Pharmaceuticals
VRTX
$102B
| $397K | 0.05% |
1,522
+100
| +7% | +$26.1K |
|
277
Dover
DOV
$24.4B
| $396K | 0.05% |
2,529
+474
| +23% | +$74.2K |
|
278
GSK
GSK
$81.5B
| $395K | 0.05% |
7,261
+525
| +8% | +$28.6K |
|
279
Cadence Design Systems
CDNS
$95.6B
| $394K | 0.05% |
2,395
+427
| +22% | +$70.2K |
|
280
Entegris
ENTG
$12.4B
| $392K | 0.05% |
2,990
+254
| +9% | +$33.3K |
|
281
Woori Financial
WF
$12.9B
| $390K | 0.05% |
10,343
+919
| +10% | +$34.7K |
|
282
Boston Scientific
BSX
$159B
| $388K | 0.05% |
8,773
+1,258
| +17% | +$55.6K |
|
283
Atlassian
TEAM
$45.2B
| $387K | 0.05% |
1,315
+94
| +8% | +$27.7K |
|
284
TE Connectivity
TEL
$61.7B
| $387K | 0.05% |
2,960
+71
| +2% | +$9.28K |
|
285
Dow Inc
DOW
$17.4B
| $383K | 0.05% |
6,008
+1,270
| +27% | +$81K |
|
286
TC Energy
TRP
$53.9B
| $382K | 0.05% |
6,764
+621
| +10% | +$35.1K |
|
287
POSCO
PKX
$15.5B
| $378K | 0.05% |
6,372
-984
| -13% | -$58.4K |
|
288
Realty Income
O
$54.2B
| $377K | 0.05% |
5,435
+243
| +5% | +$16.9K |
|
289
Vanguard Value ETF
VTV
$143B
| $375K | 0.05% |
2,535
-526
| -17% | -$77.8K |
|
290
Illumina
ILMN
$15.7B
| $373K | 0.05% |
1,098
+48
| +5% | +$16.3K |
|
291
Vanguard Small-Cap Value ETF
VBR
$31.8B
| $372K | 0.05% |
2,115
+1
| +0% | +$176 |
|
292
Clorox
CLX
$15.5B
| $371K | 0.04% |
2,671
+42
| +2% | +$5.83K |
|
293
Marathon Petroleum
MPC
$54.8B
| $369K | 0.04% |
4,320
+274
| +7% | +$23.4K |
|
294
Humana
HUM
$37B
| $368K | 0.04% |
845
+25
| +3% | +$10.9K |
|
295
National Grid
NGG
$69.6B
| $366K | 0.04% |
5,208
+308
| +6% | +$21.6K |
|
296
Palo Alto Networks
PANW
$130B
| $366K | 0.04% |
3,528
+354
| +11% | +$36.7K |
|
297
RELX
RELX
$85.9B
| $363K | 0.04% |
11,659
+1,241
| +12% | +$38.6K |
|
298
Aflac
AFL
$57.2B
| $362K | 0.04% |
5,625
+22
| +0.4% | +$1.42K |
|
299
Verisk Analytics
VRSK
$37.8B
| $362K | 0.04% |
1,686
-82
| -5% | -$17.6K |
|
300
British American Tobacco
BTI
$122B
| $361K | 0.04% |
8,552
+2,197
| +35% | +$92.7K |
|